Barcelona 2015 Programme Registration Glaucoma Day 2015 Exhibition Virtual Exhibition Satellite Meetings Hotel Booking Star Alliance
ISTANBUL escrs









Take a look inside the London 2014 Congress

video-icon

Then register to join us
in Barcelona!





Posters

Search Abstracts by author or title
(results will display both Free Papers & Poster)

Visian toric ICL implantation after sequential intracorneal ring segment implantation and corneal cross-linking in keratoconus: up to 2 years follow-up

Poster Details

First Author: Y.Abdelmassih LEBANON

Co Author(s):    H. Fakhoury   E. Slim   G. Cherfan   E. Jarade           

Abstract Details

Purpose:

Visian toric ICL implantation after sequential intracorneal ring segments implantation and corneal crosslinking in keratoconus: up to 2 years follow-up.

Setting:

Beirut Eye Specialist Hospital,Lebanon

Methods:

A retrospective study that examined the results of a 3-step ICRS-CXL-TICL in 11 eyes of 7 patients with moderate to severe keratoconus (Stages II and III of Amsler-Krumeich classification). The 2 procedures (ICRS-CXL) were performed sequentially at an interval of 4 weeks and TICL implantation was performed at least 6 months after CXL. Data were collected preoperatively, at the 6-month follow-up visit after sequential ICRS-CXL, and at the 6, 12 and 24 months following TICL implantation.

Results:

A retrospective study that examined the results of a 3-step ICRS-CXL-TICL in 11 eyes of 7 patients with moderate to severe keratoconus (Stages II and III of Amsler-Krumeich classification). The 2 procedures (ICRS-CXL) were performed sequentially at an interval of 4 weeks and TICL implantation was performed at least 6 months after CXL. Data were collected preoperatively, at the 6-month follow-up visit after sequential ICRS-CXL, and at the 6, 12 and 24 months following TICL implantation.

Conclusions:

Implatation of Visian toric ICL following sequential ICRS insertion and CXL is an effective and safe option for correcting high residual refractive error and improving visual acuity in patients with moderate to severe keratoconus and the results are maintained for up to 2 years.

Financial Disclosure:

NONE

Back to Poster listing